Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-05 Sale |
2024-07-09 4:15 pm |
Monte Rosa Therapeutics Inc. | GLUE | Dunn Edmund Principal Accounting Officer |
1,610 | $3.8301 | $6,166 | 13,944 (Direct) |
View |
| 2024-06-03 Sale |
2024-06-05 4:10 pm |
Monte Rosa Therapeutics Inc. | GLUE | Dunn Edmund Principal Accounting Officer |
1,207 | $4.0396 | $4,876 | 15,554 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-06 4:15 pm |
N/A 2035-01-01 |
Monte Rosa Therapeutics Inc. | GLUE | Dunn Edmund Principal Accounting Officer |
65,250 | $0 | 79,194 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:15 pm |
N/A 2034-01-01 |
Monte Rosa Therapeutics Inc. | GLUE | Dunn Edmund Principal Accounting Officer |
60,900 | $0 | 60,900 (Direct) |
View |
Ownership |
2023-08-18 4:00 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Dunn Edmund Principal Accounting Officer |
0 | $0 | 92,876 (Direct) |
View |